Anixa Biosciences, Inc.
ANIX
$2.79
$0.176.49%
NASDAQ
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -10.93% | -8.55% | -10.83% | -8.37% | -5.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.78% | -18.94% | -15.40% | -12.62% | 1.33% |
| Operating Income | 18.78% | 18.94% | 15.40% | 12.62% | -1.33% |
| Income Before Tax | 17.39% | 17.60% | 13.15% | 10.29% | -4.39% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 17.39% | 17.60% | 13.15% | 10.29% | -4.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -25.83% | -33.33% | -29.86% | -28.28% | -16.67% |
| Net Income | 17.31% | 17.42% | 12.96% | 10.08% | -4.65% |
| EBIT | 18.78% | 18.94% | 15.40% | 12.62% | -1.33% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 19.59% | 19.02% | 14.45% | 11.78% | -2.11% |
| Normalized Basic EPS | 19.57% | 18.92% | 14.32% | 11.67% | -2.31% |
| EPS Diluted | 19.59% | 19.02% | 14.45% | 11.78% | -2.11% |
| Normalized Diluted EPS | 19.57% | 18.92% | 14.32% | 11.67% | -2.31% |
| Average Basic Shares Outstanding | 2.81% | 1.96% | 1.74% | 2.01% | 2.55% |
| Average Diluted Shares Outstanding | 2.81% | 1.96% | 1.74% | 2.01% | 2.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |